When the Choosing Wisely campaign was launched in 2012, the stated goal of the initiative was to "spark conversation" about the necessity of certain frequently ordered tests and treatments. Currently, we are seeing evidence that Choosing Wisely recommendations--many of which are related to radiology and medical imaging--are, indeed, having an impact.
Earlier this month, research company peer60 published a report--as described in FierceMedicalImaging--which calculated that as much as $12 billion is wasted every year on unnecessary imaging. The...
Radiation therapy costs depend more on the location where the treatment is being provided and the type of facility that is providing the treatment than on factors relating to the type of patient or disease, according to a study published this month in the International Journal of Radiation Oncology.
Last December, when the United States Preventive Services Task Force recommended low-dose CT (LDCT) lung cancer screening for high-risk smokers, it was all but a foregone conclusion that the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) would follow suit and recommend it to be covered by Medicare. Of course, that narrative took a different turn this past April when MEDCAC voted not to recommend LDCT screening, much to the dismay of lung cancer screening advocates. But now, two recent studies seem have supplied evidence that supports lung cancer screening for Medicare patients.
A lawsuit has been filed in federal court against the Centers for Medicare & Medicaid Services in an effort to get it to change its policy regarding Medicare reimbursement for the use of PET beta-amyloid scans to detect Alzheimer's disease.
A secondary analysis of the National Lung Screening Trial has found that low-dose lung cancer screening is actually more effective for older high-risk patients than it is for younger ones, according to a study in the Annals of Internal Medicine.
The use of computerized physician order entry software supplemented by real-time clinical decision support is becoming an increasingly important tool in efforts to manage imaging utilization.
The comment period for the 2015 Medicare Physician Fee Schedule proposed rule ended last week and radiology and imaging-related organizations expressed their concerns about a number of issues, such as the potential for significant reimbursement reductions in radiation oncology services. One area of particular interest to these organizations has to do with the payment for the secondary interpretation of images.
The American College of Radiology and other imaging- and radiology-related organizations have submitted comments expressing a number of concerns about the proposed 2015 Medicare Physician Fee Schedule.
A survey of hospital executives has determined that the U.S. healthcare system spends at least $7.47 billion, and as much as $11.95 billion on unnecessary imaging every year.